Luigi Mangione's New York state murder trial has been adjourned until December following his defense team's motion to dismiss the charges, which arose after his guilty plea on related federal charges last week. Jury selection had been scheduled to begin September 8, but the federal plea allowed his attorneys to raise new double jeopardy concerns.
Prosecutors are due to respond to the motion to dismiss by October 9, with the defense's reply set for October 30. Judge Gregory Carro has scheduled the next court date for December 10.
The defense argues that New York's double jeopardy rules, which differ from federal law and the U.S. Constitution, are more favorable to Mangione now that the federal case has been resolved. Manhattan prosecutors, however, have indicated they intend to continue pursuing their state case against him.
Mangione, 28, pleaded guilty last Friday to federal charges of stalking UnitedHealthcare CEO Brian Thompson across state lines and subsequently shooting him outside a Manhattan hotel on December 4, 2024. Thompson, 50, was reportedly on his way to meet with investors at the time of the incident. He was a father of two from Minnesota.
Sentencing for the federal case has not yet occurred. While sentencing guidelines suggest a maximum of approximately 30 years, the presiding judge is not bound by these recommendations and could impose a sentence of life in prison without parole. If convicted on the state charges, Mangione faces a maximum sentence of 25 years to life for second-degree murder.